Overdrive pacing in the acute management of osimertinib-induced ventricular arrhythmias: A case report and literature review

QT interval prolongation and ventricular arrhythmias (VAs) induced by osimertinib, a third-generation epidermal growth factor receptor tyrosine kinase inhibitor, are life-threatening complications. However, no consensus has been achieved regarding their management. Overdrive pacing has been shown to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanyu, Wang, Xingtong, Pan, Yilin, Du, Beibei, Nanthakumar, Kumaraswamy, Yang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557095/
https://www.ncbi.nlm.nih.gov/pubmed/36247453
http://dx.doi.org/10.3389/fcvm.2022.934214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557095/
https://www.ncbi.nlm.nih.gov/pubmed/36247453
http://dx.doi.org/10.3389/fcvm.2022.934214

Ejemplares similares